The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ophthalmic Biologics Market Research Report 2025
Synopsis
The global Ophthalmic Biologics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ophthalmic Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ophthalmic Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ophthalmic Biologics include Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio
, Regeneron and Qilu Pharmaceutical Co.,Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Biologics.
Report Scope
The Ophthalmic Biologics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ophthalmic Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Novartis
Bayer
Genentech
Apellis Pharmaceuticals, Inc.
Coherus BioSciences Inc.
Iveric Bio
Regeneron
Qilu Pharmaceutical Co.,Ltd.
Chengdu Kanghong Pharmaceutical Group
Segment by Type
Ranibizumab
Bevacizumab
Aflibercept
Brolucizumab
Faricimab
Others
Segment by Application
Age-related Macular Degeneration Treatment
Diabetic Retinopathy Treatment
Inhibit Abnormal Angiogenesis
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ophthalmic Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ophthalmic Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Ophthalmic Biologics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ophthalmic Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ophthalmic Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ophthalmic Biologics include Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio
, Regeneron and Qilu Pharmaceutical Co.,Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Biologics.
Report Scope
The Ophthalmic Biologics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ophthalmic Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Novartis
Bayer
Genentech
Apellis Pharmaceuticals, Inc.
Coherus BioSciences Inc.
Iveric Bio
Regeneron
Qilu Pharmaceutical Co.,Ltd.
Chengdu Kanghong Pharmaceutical Group
Segment by Type
Ranibizumab
Bevacizumab
Aflibercept
Brolucizumab
Faricimab
Others
Segment by Application
Age-related Macular Degeneration Treatment
Diabetic Retinopathy Treatment
Inhibit Abnormal Angiogenesis
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ophthalmic Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ophthalmic Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Ophthalmic Biologics Market Overview
1.1 Product Overview and Scope of Ophthalmic Biologics
1.2 Ophthalmic Biologics Segment by Type
1.2.1 Global Ophthalmic Biologics Market Value Comparison by Type (2024-2030)
1.2.2 Ranibizumab
1.2.3 Bevacizumab
1.2.4 Aflibercept
1.2.5 Brolucizumab
1.2.6 Faricimab
1.2.7 Others
1.3 Ophthalmic Biologics Segment by Application
1.3.1 Global Ophthalmic Biologics Market Value by Application: (2024-2030)
1.3.2 Age-related Macular Degeneration Treatment
1.3.3 Diabetic Retinopathy Treatment
1.3.4 Inhibit Abnormal Angiogenesis
1.4 Global Ophthalmic Biologics Market Size Estimates and Forecasts
1.4.1 Global Ophthalmic Biologics Revenue 2019-2030
1.4.2 Global Ophthalmic Biologics Sales 2019-2030
1.4.3 Global Ophthalmic Biologics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ophthalmic Biologics Market Competition by Manufacturers
2.1 Global Ophthalmic Biologics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ophthalmic Biologics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ophthalmic Biologics Average Price by Manufacturers (2019-2024)
2.4 Global Ophthalmic Biologics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ophthalmic Biologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ophthalmic Biologics, Product Type & Application
2.7 Ophthalmic Biologics Market Competitive Situation and Trends
2.7.1 Ophthalmic Biologics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ophthalmic Biologics Players Market Share by Revenue
2.7.3 Global Ophthalmic Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ophthalmic Biologics Retrospective Market Scenario by Region
3.1 Global Ophthalmic Biologics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ophthalmic Biologics Global Ophthalmic Biologics Sales by Region: 2019-2030
3.2.1 Global Ophthalmic Biologics Sales by Region: 2019-2024
3.2.2 Global Ophthalmic Biologics Sales by Region: 2025-2030
3.3 Global Ophthalmic Biologics Global Ophthalmic Biologics Revenue by Region: 2019-2030
3.3.1 Global Ophthalmic Biologics Revenue by Region: 2019-2024
3.3.2 Global Ophthalmic Biologics Revenue by Region: 2025-2030
3.4 North America Ophthalmic Biologics Market Facts & Figures by Country
3.4.1 North America Ophthalmic Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ophthalmic Biologics Sales by Country (2019-2030)
3.4.3 North America Ophthalmic Biologics Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ophthalmic Biologics Market Facts & Figures by Country
3.5.1 Europe Ophthalmic Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ophthalmic Biologics Sales by Country (2019-2030)
3.5.3 Europe Ophthalmic Biologics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Ophthalmic Biologics Market Facts & Figures by Country
3.6.1 Asia Pacific Ophthalmic Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ophthalmic Biologics Sales by Country (2019-2030)
3.6.3 Asia Pacific Ophthalmic Biologics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Ophthalmic Biologics Market Facts & Figures by Country
3.7.1 Latin America Ophthalmic Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ophthalmic Biologics Sales by Country (2019-2030)
3.7.3 Latin America Ophthalmic Biologics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Ophthalmic Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Ophthalmic Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ophthalmic Biologics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ophthalmic Biologics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ophthalmic Biologics Sales by Type (2019-2030)
4.1.1 Global Ophthalmic Biologics Sales by Type (2019-2024)
4.1.2 Global Ophthalmic Biologics Sales by Type (2025-2030)
4.1.3 Global Ophthalmic Biologics Sales Market Share by Type (2019-2030)
4.2 Global Ophthalmic Biologics Revenue by Type (2019-2030)
4.2.1 Global Ophthalmic Biologics Revenue by Type (2019-2024)
4.2.2 Global Ophthalmic Biologics Revenue by Type (2025-2030)
4.2.3 Global Ophthalmic Biologics Revenue Market Share by Type (2019-2030)
4.3 Global Ophthalmic Biologics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ophthalmic Biologics Sales by Application (2019-2030)
5.1.1 Global Ophthalmic Biologics Sales by Application (2019-2024)
5.1.2 Global Ophthalmic Biologics Sales by Application (2025-2030)
5.1.3 Global Ophthalmic Biologics Sales Market Share by Application (2019-2030)
5.2 Global Ophthalmic Biologics Revenue by Application (2019-2030)
5.2.1 Global Ophthalmic Biologics Revenue by Application (2019-2024)
5.2.2 Global Ophthalmic Biologics Revenue by Application (2025-2030)
5.2.3 Global Ophthalmic Biologics Revenue Market Share by Application (2019-2030)
5.3 Global Ophthalmic Biologics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Ophthalmic Biologics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Ophthalmic Biologics Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Ophthalmic Biologics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Ophthalmic Biologics Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Ophthalmic Biologics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Ophthalmic Biologics Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Genentech
6.4.1 Genentech Corporation Information
6.4.2 Genentech Description and Business Overview
6.4.3 Genentech Ophthalmic Biologics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Genentech Ophthalmic Biologics Product Portfolio
6.4.5 Genentech Recent Developments/Updates
6.5 Apellis Pharmaceuticals, Inc.
6.5.1 Apellis Pharmaceuticals, Inc. Corporation Information
6.5.2 Apellis Pharmaceuticals, Inc. Description and Business Overview
6.5.3 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product Portfolio
6.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
6.6 Coherus BioSciences Inc.
6.6.1 Coherus BioSciences Inc. Corporation Information
6.6.2 Coherus BioSciences Inc. Description and Business Overview
6.6.3 Coherus BioSciences Inc. Ophthalmic Biologics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Coherus BioSciences Inc. Ophthalmic Biologics Product Portfolio
6.6.5 Coherus BioSciences Inc. Recent Developments/Updates
6.7 Iveric Bio
6.6.1 Iveric Bio
Corporation Information
6.6.2 Iveric Bio
Description and Business Overview
6.6.3 Iveric Bio
Ophthalmic Biologics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Iveric Bio
Ophthalmic Biologics Product Portfolio
6.7.5 Iveric Bio
Recent Developments/Updates
6.8 Regeneron
6.8.1 Regeneron Corporation Information
6.8.2 Regeneron Description and Business Overview
6.8.3 Regeneron Ophthalmic Biologics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Regeneron Ophthalmic Biologics Product Portfolio
6.8.5 Regeneron Recent Developments/Updates
6.9 Qilu Pharmaceutical Co.,Ltd.
6.9.1 Qilu Pharmaceutical Co.,Ltd. Corporation Information
6.9.2 Qilu Pharmaceutical Co.,Ltd. Description and Business Overview
6.9.3 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product Portfolio
6.9.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.10 Chengdu Kanghong Pharmaceutical Group
6.10.1 Chengdu Kanghong Pharmaceutical Group Corporation Information
6.10.2 Chengdu Kanghong Pharmaceutical Group Description and Business Overview
6.10.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product Portfolio
6.10.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ophthalmic Biologics Industry Chain Analysis
7.2 Ophthalmic Biologics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ophthalmic Biologics Production Mode & Process
7.4 Ophthalmic Biologics Sales and Marketing
7.4.1 Ophthalmic Biologics Sales Channels
7.4.2 Ophthalmic Biologics Distributors
7.5 Ophthalmic Biologics Customers
8 Ophthalmic Biologics Market Dynamics
8.1 Ophthalmic Biologics Industry Trends
8.2 Ophthalmic Biologics Market Drivers
8.3 Ophthalmic Biologics Market Challenges
8.4 Ophthalmic Biologics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Ophthalmic Biologics Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Ophthalmic Biologics Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Ophthalmic Biologics Market Competitive Situation by Manufacturers in 2023
Table 4. Global Ophthalmic Biologics Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Ophthalmic Biologics Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Ophthalmic Biologics Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Ophthalmic Biologics Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Ophthalmic Biologics Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Ophthalmic Biologics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Ophthalmic Biologics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ophthalmic Biologics, Product Type & Application
Table 12. Global Key Manufacturers of Ophthalmic Biologics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ophthalmic Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Biologics as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ophthalmic Biologics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Ophthalmic Biologics Sales by Region (2019-2024) & (K Units)
Table 18. Global Ophthalmic Biologics Sales Market Share by Region (2019-2024)
Table 19. Global Ophthalmic Biologics Sales by Region (2025-2030) & (K Units)
Table 20. Global Ophthalmic Biologics Sales Market Share by Region (2025-2030)
Table 21. Global Ophthalmic Biologics Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Ophthalmic Biologics Revenue Market Share by Region (2019-2024)
Table 23. Global Ophthalmic Biologics Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Ophthalmic Biologics Revenue Market Share by Region (2025-2030)
Table 25. North America Ophthalmic Biologics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Ophthalmic Biologics Sales by Country (2019-2024) & (K Units)
Table 27. North America Ophthalmic Biologics Sales by Country (2025-2030) & (K Units)
Table 28. North America Ophthalmic Biologics Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Ophthalmic Biologics Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Ophthalmic Biologics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Ophthalmic Biologics Sales by Country (2019-2024) & (K Units)
Table 32. Europe Ophthalmic Biologics Sales by Country (2025-2030) & (K Units)
Table 33. Europe Ophthalmic Biologics Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Ophthalmic Biologics Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Ophthalmic Biologics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Ophthalmic Biologics Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Ophthalmic Biologics Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Ophthalmic Biologics Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Ophthalmic Biologics Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Ophthalmic Biologics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Ophthalmic Biologics Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Ophthalmic Biologics Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Ophthalmic Biologics Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Ophthalmic Biologics Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Ophthalmic Biologics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Ophthalmic Biologics Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Ophthalmic Biologics Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Ophthalmic Biologics Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Ophthalmic Biologics Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Ophthalmic Biologics Sales (K Units) by Type (2019-2024)
Table 51. Global Ophthalmic Biologics Sales (K Units) by Type (2025-2030)
Table 52. Global Ophthalmic Biologics Sales Market Share by Type (2019-2024)
Table 53. Global Ophthalmic Biologics Sales Market Share by Type (2025-2030)
Table 54. Global Ophthalmic Biologics Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Ophthalmic Biologics Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Ophthalmic Biologics Revenue Market Share by Type (2019-2024)
Table 57. Global Ophthalmic Biologics Revenue Market Share by Type (2025-2030)
Table 58. Global Ophthalmic Biologics Price (US$/Unit) by Type (2019-2024)
Table 59. Global Ophthalmic Biologics Price (US$/Unit) by Type (2025-2030)
Table 60. Global Ophthalmic Biologics Sales (K Units) by Application (2019-2024)
Table 61. Global Ophthalmic Biologics Sales (K Units) by Application (2025-2030)
Table 62. Global Ophthalmic Biologics Sales Market Share by Application (2019-2024)
Table 63. Global Ophthalmic Biologics Sales Market Share by Application (2025-2030)
Table 64. Global Ophthalmic Biologics Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Ophthalmic Biologics Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Ophthalmic Biologics Revenue Market Share by Application (2019-2024)
Table 67. Global Ophthalmic Biologics Revenue Market Share by Application (2025-2030)
Table 68. Global Ophthalmic Biologics Price (US$/Unit) by Application (2019-2024)
Table 69. Global Ophthalmic Biologics Price (US$/Unit) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sanofi Ophthalmic Biologics Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Novartis Ophthalmic Biologics Product
Table 79. Novartis Recent Developments/Updates
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bayer Ophthalmic Biologics Product
Table 84. Bayer Recent Developments/Updates
Table 85. Genentech Corporation Information
Table 86. Genentech Description and Business Overview
Table 87. Genentech Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Genentech Ophthalmic Biologics Product
Table 89. Genentech Recent Developments/Updates
Table 90. Apellis Pharmaceuticals, Inc. Corporation Information
Table 91. Apellis Pharmaceuticals, Inc. Description and Business Overview
Table 92. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product
Table 94. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
Table 95. Coherus BioSciences Inc. Corporation Information
Table 96. Coherus BioSciences Inc. Description and Business Overview
Table 97. Coherus BioSciences Inc. Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Coherus BioSciences Inc. Ophthalmic Biologics Product
Table 99. Coherus BioSciences Inc. Recent Developments/Updates
Table 100. Iveric Bio
Corporation Information
Table 101. Iveric Bio
Description and Business Overview
Table 102. Iveric Bio
Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Iveric Bio
Ophthalmic Biologics Product
Table 104. Iveric Bio
Recent Developments/Updates
Table 105. Regeneron Corporation Information
Table 106. Regeneron Description and Business Overview
Table 107. Regeneron Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Regeneron Ophthalmic Biologics Product
Table 109. Regeneron Recent Developments/Updates
Table 110. Qilu Pharmaceutical Co.,Ltd. Corporation Information
Table 111. Qilu Pharmaceutical Co.,Ltd. Description and Business Overview
Table 112. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product
Table 114. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 115. Chengdu Kanghong Pharmaceutical Group Corporation Information
Table 116. Chengdu Kanghong Pharmaceutical Group Description and Business Overview
Table 117. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product
Table 119. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Ophthalmic Biologics Distributors List
Table 123. Ophthalmic Biologics Customers List
Table 124. Ophthalmic Biologics Market Trends
Table 125. Ophthalmic Biologics Market Drivers
Table 126. Ophthalmic Biologics Market Challenges
Table 127. Ophthalmic Biologics Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ophthalmic Biologics
Figure 2. Global Ophthalmic Biologics Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Ophthalmic Biologics Market Share by Type in 2023 & 2030
Figure 4. Ranibizumab Product Picture
Figure 5. Bevacizumab Product Picture
Figure 6. Aflibercept Product Picture
Figure 7. Brolucizumab Product Picture
Figure 8. Faricimab Product Picture
Figure 9. Others Product Picture
Figure 10. Global Ophthalmic Biologics Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Ophthalmic Biologics Market Share by Application in 2023 & 2030
Figure 12. Age-related Macular Degeneration Treatment
Figure 13. Diabetic Retinopathy Treatment
Figure 14. Inhibit Abnormal Angiogenesis
Figure 15. Global Ophthalmic Biologics Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Ophthalmic Biologics Market Size (2019-2030) & (US$ Million)
Figure 17. Global Ophthalmic Biologics Sales (2019-2030) & (K Units)
Figure 18. Global Ophthalmic Biologics Average Price (US$/Unit) & (2019-2030)
Figure 19. Ophthalmic Biologics Report Years Considered
Figure 20. Ophthalmic Biologics Sales Share by Manufacturers in 2023
Figure 21. Global Ophthalmic Biologics Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Ophthalmic Biologics Players: Market Share by Revenue in 2023
Figure 23. Ophthalmic Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Ophthalmic Biologics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Ophthalmic Biologics Sales Market Share by Country (2019-2030)
Figure 26. North America Ophthalmic Biologics Revenue Market Share by Country (2019-2030)
Figure 27. United States Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Ophthalmic Biologics Sales Market Share by Country (2019-2030)
Figure 30. Europe Ophthalmic Biologics Revenue Market Share by Country (2019-2030)
Figure 31. Germany Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Netherlands Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Ophthalmic Biologics Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Ophthalmic Biologics Revenue Market Share by Region (2019-2030)
Figure 38. China Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Australia Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Ophthalmic Biologics Sales Market Share by Country (2019-2030)
Figure 46. Latin America Ophthalmic Biologics Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Colombia Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Ophthalmic Biologics Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Ophthalmic Biologics Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Ophthalmic Biologics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Ophthalmic Biologics by Type (2019-2030)
Figure 57. Global Revenue Market Share of Ophthalmic Biologics by Type (2019-2030)
Figure 58. Global Ophthalmic Biologics Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Ophthalmic Biologics by Application (2019-2030)
Figure 60. Global Revenue Market Share of Ophthalmic Biologics by Application (2019-2030)
Figure 61. Global Ophthalmic Biologics Price (US$/Unit) by Application (2019-2030)
Figure 62. Ophthalmic Biologics Value Chain
Figure 63. Ophthalmic Biologics Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
